Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olopatadine 0.1% Efficacy using OHIO Chamber
NCT00818805Phase 4Completed
- Sponsor
- Alcon Inc.
- Start
- Jul 2008
- Primary completion
- Jul 2008
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of olopatadine in seasonal allergic conjunctivitis (SAC), sponsored by Alcon Inc.. Started Jul 2008; status: completed.
02
Drugs
olopatadine
03
Conditions
seasonal allergic conjunctivitis (SAC)
Beyond the preview
Go deeper on NCT00818805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00818805.